Association Between Change in Body Composition and Physical Function: A SURMOUNT-1 Post-Hoc Analysis

被引：0
|
作者：
Stefanski, Adam
Cao, Dachuang
Gibble, Theresa Hunter
Garcia-Perez, Luis-Emilio
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-373
引用
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [1] Change in Body Composition With Tirzepatide in Adults With Early-Onset Obesity in SURMOUNT-1
    Mojdami, Donna
    Cao, Dachuang
    Lee, Clare
    Gougari, Evgenia
    Murphy, Madhumita
    OBESITY, 2024, 32 : 40 - 40
  • [2] Inflammatory biomarkers in people treated with tirzepatide living with overweight or obesity, without and with T2D: a post-hoc analysis from SURMOUNT-1 and SURMOUNT-2
    Sattar, Naveed
    Verma, Subodh
    Sourij, Harald
    Wilson, Jonathan
    Stefanski, Adam
    Zhang, Xiaotian
    Griffin, Ryan
    Ruotolo, Giacomo
    Linetzky, Bruno
    CIRCULATION, 2024, 150
  • [3] Body Mass Index Shift and Associated Cardiometabolic Risk Factors in People With Obesity or Overweight: A Post Hoc Analysis From SURMOUNT-1
    Sattar, Naveed
    Srinath, Reshmi
    He, Xuanyao
    Falcon, Beverly L.
    Lee, Clare J.
    Stefanski, Adam
    Plat, Arian
    CIRCULATION, 2023, 148
  • [4] Tirzepatide Reduces the Predicted Risk of Developing Type 2 Diabetes-Post Hoc Analysis of the SURMOUNT-1 Trial
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hongjun
    Wang, Fangyu
    Ahmad, Nadia
    Garvey, W. Timothy
    DIABETES, 2023, 72
  • [5] Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
    Look, Michelle
    Dunn, Julia P.
    Kushner, Robert F.
    Cao, Dachuang
    Harris, Charles
    Gibble, Theresa Hunter
    Stefanski, Adam
    Griffin, Ryan
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2720 - 2729
  • [6] Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hong
    Wang, Fangyu
    Ahmad, Nadia N.
    Stefanski, Adam
    Garvey, W. Timothy
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3748 - 3756
  • [7] Effect of Tirzepatide on Kidney Function in People with Excess Body Weight and Type 2 Diabetes-A Post-Hoc Analysis of the SURMOUNT-2 Trial
    Heerspink, Hiddo L.
    Friedman, Allon
    Bjornstad, Petter
    Van Raalte, Daniel
    Cao, Dachuang
    Garcia-Perez, Luis-Emilio
    Stefanski, Adam
    Turfanda, Ibrahim
    Bunck, Mathijs C.
    Benabbad, Imane
    De Oliveira, Carolina Piras
    Griffin, Ryan
    DIABETES, 2024, 73
  • [8] Association between physical activity and clinical outcomes in high-risk hypertension: Post-hoc analysis of SPRINT
    Kazibwe, Richard
    Singleton, Matthew J.
    Chevli, Parag A.
    Kaze, Arnaud D.
    Namutebi, Juliana H.
    Shapiro, Michael D.
    Yeboah, Joseph
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 16
  • [9] Baseline Characteristics of Tirzepatide-Treated Participants Who Shifted to a Normal Body Mass Index (<25 kg/m2): A Post Hoc Analysis From SURMOUNT-1
    Srinath, Reshmi
    Sattar, Naveed
    He, Xuanyao
    Plat, Arian
    Falcon, Beverly L.
    Stefanski, Adam
    Lee, Clare J.
    CIRCULATION, 2023, 148
  • [10] Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hong
    Wang, Fangyu
    Ahmad, Nadia N.
    Griffin, Ryan
    Stefanski, Adam
    Garvey, W. Timothy
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 319 - 328
12345